More and more biosimilars are entering the market across a wide variety of specialties. That’s why Spotlight on Biosimilars is here to break down everything you need to know about this novel class of drugs, like the benefits, challenges, and other key considerations.
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
How Biosimilars Can Enhance the Lives—and Savings—of Rheumatoid Arthritis Patients
How Biosimilars Can Enhance the Lives—and Savings—of Rheumatoid Arthritis Patients
Examining the Economic Impacts of Biosimilars in Oncology
Examining the Economic Impacts of Biosimilars in Oncology
A Vision for Change: Exploring Biosimilars in Retinal Disease Management
A Vision for Change: Exploring Biosimilars in Retinal Disease Management
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Breaking Down Biosimilar Insulins: A Look at the Regulatory Process and Impacts
Educating Providers and Patients About Insulin Biosimilars
Educating Providers and Patients About Insulin Biosimilars
The Increasing Incidence of IBD and the Use of Biosimilars
The Increasing Incidence of IBD and the Use of Biosimilars
Interchangeability and Biologics, Biosimilars, and Generics
Interchangeability and Biologics, Biosimilars, and Generics
Biosimilars in Psoriasis: The Future of Treatment
Biosimilars in Psoriasis: The Future of Treatment
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
The Safety and Efficacy of Biosimilars in the Treatment of Rheumatoid Arthritis
The Safety and Efficacy of Biosimilars in the Treatment of Rheumatoid Arthritis
APP Biosimilar Education Video Series Module 1
APP Biosimilar Education Video Series Module 1
APP Biosimilar Education Video Series Module 2
APP Biosimilar Education Video Series Module 2
